Healthtech Startups

Perimeter Medical Imaging AI develops ultra-high resolution imaging tools and AI software to help surgeons assess tumor margins during cancer surgery in real-time. The Toronto-based company aims to reduce the need for repeat surgeries by enabling surgeons to detect remaining cancer cells using proprietary Optical Coherence Tomography technology.

2 investors

VistaApex Solutions is a dental healthcare company formed by uniting the VistaApex, PerioProtect, and PerioSciences brands, offering products such as antioxidant-based oral care, FDA-cleared non-invasive tray therapy for gum disease, and clinical endodontic and operatory materials. It serves dentists and dental patients with research-driven oral healthcare products.

2 investors

Periotherapia develops antibody-based therapeutics targeting pathological periostin in the stromal environment to treat refractory diseases including cancer, diabetic retinopathy, and heart disease. The company, spun out from Osaka University, is conducting clinical trials for HER2-negative triple-negative breast cancer with support from Japan's AMED program.

2 investors

PerioTrap develops a microbiome-friendly toothpaste that selectively targets harmful oral bacteria while preserving beneficial bacteria, using patented PerioTrap® technology designed to reduce gum inflammation risk. The company manufactures products in Germany for consumers seeking targeted gum health support.

2 investors

PeriVision develops the VisionOne platform, combining AI, virtual reality, and cloud technology to test and understand visual function for eye conditions such as glaucoma. Its systems target ophthalmology practices and hospitals, aiming to improve testing workflows and provide deeper clinical insight into eye diseases.

2 investors

PerkinElmer is a scientific instrument and technology company that provides analytical tools and services for research, diagnostics, and life sciences applications. The company operates globally with a focus on enabling scientific discovery and sustainability.

2 investors

Perosphere is a medical technology company developing point-of-care coagulation diagnostics, including a pharmacodynamic test that provides a global view of a patient's coagulation status. Its lead product is CE Marked in the European Union but not FDA cleared in the United States.

2 investors

Perspectives Health provides AI-powered clinical documentation and utilization review management for healthcare providers. The platform automates nightly chart audits, generates utilization review packets, manages documentation workflows, and tracks compliance issues for clinical teams.

2 investors

Perspectum develops digital medical technology and diagnostics using multiparametric MRI to assess and diagnose chronic systemic diseases including liver disease, long COVID, diabetes, and cancer for clinicians and patients.

2 investors

Petastic provides a digital health and wellness platform for pet owners that centralizes pet medical records, care history, and milestones in one place while connecting verified caregivers. The platform uses AI to personalize pet care recommendations and simplify daily pet management.

2 investors

Petfolk operates veterinary clinics offering in-person and app-based pet care, including 24/7 messaging, appointment booking, and digital records for pet owners. It provides a membership plan with round-the-clock support and savings, positioning itself as a modern, tech-enabled veterinary care provider.

2 investors

Jaan Health builds AI-driven software for medical groups, health systems, and ACOs to deliver proactive chronic disease management across their patient populations. Its platform, Phamily, helps physicians and care teams shift from reactive to proactive care while reducing administrative paperwork.

2 investors

Pharaoh Neuro is a neurotechnology company focused on protecting and restoring brain health, with an emphasis on the fluids surrounding the brain such as cerebrospinal fluid. It develops devices and technology in the neurology and brain health category.

2 investors

PBR Life Sciences provides AI-powered analytics and market intelligence for healthcare organizations operating in emerging markets, particularly in Sub-Saharan Africa. The company delivers data-as-a-service insights to pharmaceutical companies, NGOs, and life sciences organizations.

2 investors

PharmaSecure provides encryption-based serialization, track-and-trace, and anti-counterfeiting solutions for pharmaceutical manufacturers, integrating hardware and software across packaging lines to meet regulatory mandates such as India's GS1 QR code requirements. It also offers a loyalty platform for engaging customers, retailers, and influencers.

2 investors

Pharmeon operates Uw Zorg Online, a Dutch healthcare platform and app that lets patients book appointments, request repeat prescriptions, and contact their care providers online. It serves patients and healthcare providers such as general practitioner practices in the Netherlands.

2 investors

Pharmesol builds a network of AI agents that automate manual, fragmented processes across healthcare systems and workflows, aiming to make medications safer and easier for patients and clinicians. The platform handles routine operational tasks and turns interactions into insights for care teams.

2 investors

PharOS develops and markets generic and value-added pharmaceutical products for distribution to more than 115 countries. The company employs scientists, biologists, chemists, and pharmacists focused on drug development with emphasis on customer service and product lifecycle extension.

2 investors

PhaseBio is a company focused on developing treatments for cardiovascular disease, which is a leading cause of death in the United States.

2 investors

PHC Global builds AI-driven systems that fuse distributed biological data streams (wastewater, clinical, syndromic, environmental) with contextual intelligence to detect anomalies and produce decision-ready biological threat intelligence. Its commercial software platform serves defense, public safety, and U.S. Fortune 500 enterprises for biosurveillance and operational risk protection.

2 investors

Pheast Therapeutics develops immunotherapies targeting cancer, building on foundational research from Stanford's stem cell research institute. The company focuses on translating scientific discoveries into clinical therapies for patients.

2 investors

Phenomix Sciences applies data analytics and patient data to enable precision obesity medicine, aiming to guide treatment decisions for anti-obesity medications such as GLP-1s and reduce care costs. Its platform-based approach targets the healthcare market for obesity treatment.

2 investors

Phenota develops automation technology for hematology laboratories, applying Raman spectroscopy to routine blood testing for real-time analysis. It targets clinical diagnostic labs with tools built around their workflow.

2 investors

Pheon Therapeutics develops targeted oncology treatments, focusing on antibody-drug conjugates (ADCs) for cancer therapy.

2 investors